Coeptis Therapeutics Holdings Cash Flow Statement (2021-2025) | COEP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Share-based Compensation 3.54M0.18M0.90M0.36M2.40M1.07M0.53M0.42M0.54M0.56M0.05M0.18M0.60M1.81M0.32M
Gains from Investment Securities -14.21M1.65M-4.28M16.84M-0.60M-0.15M0.54M
Non-cash Items 1.32M1.21M1.09M1.13M
Cash from Operations -0.14M-0.12M-0.06M-4.17M-0.96M-1.03M-1.03M-0.85M-1.68M-1.90M-1.96M-1.69M-1.90M-1.42M-1.89M-1.44M-2.37M-2.40M-2.15M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00M0.15M0.07M0.10M0.39M0.06M
Depreciation & Amortization (CF) 0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.30M0.30M0.30M
Change in Working Capital
Change in Receivables 0.01M-0.01M0.05M
Change in Account Payables 0.11M0.02M0.06M-0.23M0.14M0.15M0.09M0.94M-0.05M-0.08M-0.15M0.14M-0.15M-0.09M-0.24M
Change in Accured Expenses 0.03M0.00M0.01M-0.47M0.07M0.04M0.05M-0.18M0.11M0.13M0.14M-0.01M0.16M0.09M-0.03M0.01M-0.13M-0.19M-0.09M
Other Working Capital Changes 0.03M-0.03M-0.03M-0.97M0.00M-208.00-207.000.49M-0.02M-0.01M-0.04M-0.01M-0.05M-0.04M-0.07M0.28M-0.14M-0.08M-0.17M
Investing Activities
Cash from Investing Activities -0.35M0.35M-0.10M0.10M
Financing Activities
Cash from Financing Activities 1.13M1.07M6.03M-2.73M3.39M-0.22M1.75M1.56M1.94M1.47M0.73M6.10M0.13M5.06M
Additional items
Change in Cash -0.14M-0.12M-0.06M2.30M0.16M0.03M4.99M-3.58M-1.68M1.14M-1.83M0.06M-0.44M0.53M-0.42M-0.60M3.74M-2.27M2.91M
Free Cash Flow -0.14M-0.12M-0.06M-4.17M-0.96M-1.03M-1.03M-0.85M-1.68M-1.90M-1.96M-1.69M-1.90M-1.42M-1.89M-1.44M-2.37M-2.40M-2.15M
Net Cash Flow -0.14M-0.12M-0.06M-4.17M0.16M0.03M4.99M-3.58M-1.68M1.14M-1.83M0.06M-0.44M0.53M-0.42M-0.60M3.74M-2.27M2.91M